Literature DB >> 25819857

Parkinson disease and risk of acute myocardial infarction: A population-based, propensity score-matched, longitudinal follow-up study.

Huey-Wen Liang1, Ya-Ping Huang2, Shin-Liang Pan3.   

Abstract

OBJECTIVES: Previous studies on the risk of acute myocardial infarction (AMI) in patients with Parkinson disease (PD) have generated inconsistent results. The purpose of this population-based longitudinal follow-up study was to investigate whether incident PD is associated with an increased risk of AMI.
METHODS: A total of 3,211 subjects with at least 2 ambulatory visits with the principal diagnosis of PD in 2001 were enrolled in the PD group. The non-PD group consisted of 3,211 propensity score-matched subjects without PD. The propensity scores were computed using a logistic regression model that included age, sex, preexisting comorbidities, and socioeconomic status. The 3-year AMI-free survival rates of the 2 groups were estimated using the Kaplan-Meier method. Stratified Cox proportional hazard regression with patients matched by propensity score was used to estimate the effect of PD on subsequent occurrence of AMI.
RESULTS: During the 3-year follow-up period, 83 subjects in the PD group and 53 in the non-PD group developed AMI (either fatal or nonfatal) events. The hazard ratio of AMI for the PD group compared with the non-PD group was 1.67 (95% CI 1.15-2.41, P = .0067). The AMI-free survival rate of the PD group was significantly lower than that of the non-PD group (P = .0032). The hazard ratios associated with PD for the combined end point 1 (AMI or cardiovascular death) and combined end point 2 (AMI or all-cause death) were 1.46 (95% CI 1.14-1.88, P = .0029) and 1.42 (95% CI 1.24-1.64, P < .0001), respectively.
CONCLUSIONS: This study shows that PD is related to an increased risk of AMI. Further studies are required to investigate the mechanism underlying this association.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25819857     DOI: 10.1016/j.ahj.2014.11.018

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  11 in total

1.  Role of plasminogen activator inhibitor-1 in the diagnosis and prognosis of patients with Parkinson's disease.

Authors:  Hong Pan; Ying Zhao; Zhengping Zhai; Jinyu Zheng; Yong Zhou; Qijin Zhai; Xiangyang Cao; Jisha Tian; Liandong Zhao
Journal:  Exp Ther Med       Date:  2018-04-17       Impact factor: 2.447

2.  Understanding the links between cardiovascular disease and Parkinson's disease.

Authors:  Judy Potashkin; Xuemei Huang; Claudia Becker; Honglei Chen; Thomas Foltynie; Connie Marras
Journal:  Mov Disord       Date:  2019-09-04       Impact factor: 10.338

3.  Central hemodynamics and arterial stiffness in idiopathic and multiple system atrophy.

Authors:  Klaas Franzen; Sabine Fliegen; Jelena Koester; Rafael Campos Martin; Günther Deuschl; Michael Reppel; Kai Mortensen; Susanne A Schneider
Journal:  J Neurol       Date:  2016-11-29       Impact factor: 4.849

Review 4.  Cardiac Involvement in Movement Disorders.

Authors:  Malco Rossi; Nestor Wainsztein; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2021-04-07

5.  The Relationship between Parkinson's Disease and Acute Myocardial Infarction in Korea : A Nationwide Longitudinal Cohort Study.

Authors:  Seung Hun Sheen; Je Beom Hong; Hakyung Kim; Jimin Kim; In-Bo Han; Seil Sohn
Journal:  J Korean Neurosurg Soc       Date:  2022-03-02

6.  Evaluation of cardiovascular risk in patients with Parkinson disease under levodopa treatment.

Authors:  Zeki Yüksel Günaydın; Fahriye Feriha Özer; Ahmet Karagöz; Osman Bektaş; Mehmet Baran Karataş; Aslı Vural; Adil Bayramoğlu; Abdullah Çelik; Mehmet Yaman
Journal:  J Geriatr Cardiol       Date:  2016-01       Impact factor: 3.327

7.  Cardiometabolic risk factors in primary centred and rotator cuff-related shoulder osteoarthritis: a comparative study.

Authors:  Pierre-Antoine Juge; Laure Berard; Salma Kotti; Levon Doursounian; Alain Sautet; Tabassome Simon; Francis Berenbaum; Geoffroy Nourissat; Jérémie Sellam
Journal:  RMD Open       Date:  2017-06-29

8.  Prevalent cerebrovascular and cardiovascular disease in people with Parkinson's disease: a meta-analysis.

Authors:  Lung Chan; Chyi-Huey Bai; Chien Tai Hong; Han-Hwa Hu
Journal:  Clin Epidemiol       Date:  2018-09-04       Impact factor: 4.790

9.  Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease.

Authors:  Christel Renoux; Sophie Dell'Aniello; Paul Khairy; Connie Marras; Shawn Bugden; Tanvir Chowdhury Turin; Lucie Blais; Hala Tamim; Charity Evans; Russell Steele; Colin Dormuth; Pierre Ernst
Journal:  Br J Clin Pharmacol       Date:  2016-05-19       Impact factor: 4.335

Review 10.  Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson's Disease.

Authors:  Shubhra Acharya; Antonio Salgado-Somoza; Francesca Maria Stefanizzi; Andrew I Lumley; Lu Zhang; Enrico Glaab; Patrick May; Yvan Devaux
Journal:  Int J Mol Sci       Date:  2020-09-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.